AVEO PHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
AVEO PHARMACEUTICALS, INC. has filed 1,019 SEC EDGAR filings since 27 Apr 2005

SEC filing history

Showing 901-925 of 1,000 matching filings.

Per page
25
Current page
37
4

4 filing

Filing date
17 Feb 2011
Reporting date
15 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Feb 2011
Reporting date
17 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

EZICKSON FORM 4

Filing date
17 Feb 2011
Reporting date
15 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

HA-NGOC FORM 4 - 10.12.10

Filing date
17 Feb 2011
Reporting date
15 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

SLICHENMYER FORM 4

Filing date
17 Feb 2011
Reporting date
15 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-170535

FORM 424(B)(3)

Filing date
17 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34655

FORM 8-K

Filing date
16 Feb 2011
Reporting date
16 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
5

WEG FORM 5 FOR 2010

Filing date
15 Feb 2011
Reporting date
31 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

HA-NGOC FORM 4/A

Filing date
15 Feb 2011
Reporting date
12 Oct 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

BATE FORM 3/A

Filing date
15 Feb 2011
Reporting date
11 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85745

DOC ONE

Filing date
14 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-85745

SC 13G

Filing date
14 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-85745

AVEO PHARMACEUTICALS, INC.

Filing date
11 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-85745

AVEO13GORIG

Filing date
11 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

SLICHENMYER FORM 4

Filing date
20 Jan 2011
Reporting date
18 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

GYURIS FORM 4

Filing date
13 Jan 2011
Reporting date
11 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

SLICHENMYER FORM 4

Filing date
13 Jan 2011
Reporting date
10 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

EZICKSON FORM 4

Filing date
13 Jan 2011
Reporting date
10 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-170535

424(B)(3)

Filing date
10 Jan 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34655

FORM 8-K

Filing date
10 Jan 2011
Reporting date
10 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

SLICHENMYER FORM 4

Filing date
05 Jan 2011
Reporting date
04 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

COLE FORM 4

Filing date
03 Jan 2011
Reporting date
30 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

COLE FORM 4

Filing date
29 Dec 2010
Reporting date
28 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

COLE FORM 4

Filing date
27 Dec 2010
Reporting date
23 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

COLE FORM 4

Filing date
22 Dec 2010
Reporting date
21 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .